Cancer

Items 291-300 of 1000

per page
Set Descending Direction
  1. anti-SLP-2, pAb
    AG-25B-0019
    AG-25B-0019-C100100 µg
    CHF 440.00
    Endogenous SLP-2 is localized to the mitochondria (Immunocytochemical staining).  Endogenous SLP-2 (green) (up) and endogenous mitochondrial HSP70 (red) (middle) were detected in methanol fixed HeLa cells using anti-SLP-2, pAb (Prod. No. AG-20B-0019
  2. anti-Sortilin (human), mAb (rec.) (blocking) (preservative free) [Latozinemab]
    AG-27B-7000PF
    AG-27B-7000PF-C100100 µg
    CHF 420.00
    AG-27B-7000PF-C500500 µg
    CHF 1'600.00
    anti-Sortilin (human), mAb (rec.) (blocking) (preservative free) [Latozinemab]
  3. anti-TDO (human), pAb
    AG-25A-0106
    AG-25A-0106-C100100 µg
    CHF 190.00
    Western blot analysis using anti-TDO (human), pAb (Prod. No. AG-25A-0106) at 1:2'000 dilution.
1: Human TDO (His-tagged).
2: Human IDO (His-tagged).
3: Mouse IDO (His-tagged).
4: SH-sy5y cell lysate.
5: Unrelated protein (His
  4. anti-TIE-2 (human), mAb (tek16)
    AG-20T-0104
    AG-20T-0104-C100100 µg
    CHF 435.00
    anti-TIE-2 (human), mAb (tek16)
  5. anti-TIE-2 (human), mAb (tek2)
    AG-20T-0102
    AG-20T-0102-C100100 µg
    CHF 435.00
    anti-TIE-2 (human), mAb (tek2)
  6. anti-TIE-2 (human), mAb (tek9)
    AG-20T-0103
    AG-20T-0103-C100100 µg
    CHF 435.00
    anti-TIE-2 (human), mAb (tek9)
  7. anti-TNF-α (mouse), mAb (blocking) (V1q) (preservative free)
    AG-20B-0081PF
    AG-20B-0081PF-C100100 µg
    CHF 360.00
    AG-20B-0081PF-C500500 µg
    CHF 1'080.00
    anti-TNF-α (mouse), mAb (blocking) (V1q) (preservative free)
  8. anti-TRAIL (human), mAb (HS501)
    AG-20B-0026
    AG-20B-0026-C100100 µg
    CHF 420.00
  9. anti-TRAIL-R1 (human), mAb (HS101)
    AG-20B-0022
    AG-20B-0022-C100100 µg
    CHF 460.00
  10. anti-TRAIL-R1 (human), mAb (HS101) (ATTO 488)
    AG-20B-0022TD
    AG-20B-0022TD-T100100 tests
    CHF 490.00

Items 291-300 of 1000

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.